GGrantIndex
Sort

10,766 grants matching checkpoint inhibitor

Mechanisms of Resistance to Cell Cycle Checkpoint Kinase Inhibitors

$294,696
Alan R Eastman · Dartmouth College · R01 · FY2011 · CA

Project 3- Integrated Stress and Interferon Responses

$294,512
Serge Y Fuchs · University Of Pennsylvania · P01 · FY2023 · CA

Role of PI3Kinase in Tumor Progression and Metastasis

$294,438
Judith A. Varner · University Of California, San Diego · R01 · FY2020 · CA

Project 3: KDM5 Histone Demethylases in Melanoma Growth and Tumor Immunity

$294,427
Qin Yan · Yale University · P50 · FY2022 · CA

Project 2- Liquid Biopsies for Melanoma that Metastasizes to Inaccessible Sites

$294,426
David A. Hafler · Yale University · P50 · FY2022 · CA

P34CDC2 AND CELL CYCLE CONTROL

$294,357
Washington University · R01 · FY2000 · GM

The Mammalian Cell Cycle Control and Tumor Genesis

$294,173
Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2007 · CA

The Mammalian Cell Cycle Control and Tumor Genesis

$294,172
Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2008 · CA

The Mammalian Cell Cycle Control and Tumor Genesis

$294,172
Yue Xiong · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA

Project 2

$294,092
Tomas Kirchhoff · New York University School Of Medicine · P50 · FY2023 · CA

Molecular Genetic Epidemiology of leading U.S. Cancers

$293,848
Kenneth H Buetow · Cancer Epidemiology And Genetics · Z01 · FY2007 · CA

Mechanisms of Telomere Function

$293,751
Susan Smith · New York University School Of Medicine · R01 · FY2006 · CA

Mitotic Catastrophe in Tumor Cells

$293,700
Ordway Research Institute, Inc. · R01 · FY2005 · CA

Mitotic Catastrophe in Tumor Cells

$293,700
Ordway Research Institute, Inc. · R01 · FY2004 · CA

Targeted Therapy for Endometrial Cancer

$293,550
Kimberly K Leslie · University Of Iowa · R01 · FY2020 · CA

(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors

$293,469
Kevan C Herold · Yale University · R01 · FY2018 · CA

G2 Role For Cdk2 in Human Cells

$293,225
University Of Pennsylvania · R01 · FY2005 · GM

BUB1 in Chromosomal Instability and Tumorigenesis

$293,037
Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2016 · CA

BUB1 in Chromosomal Instability and Tumorigenesis

$293,037
Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2015 · CA

BUB1 in Chromosomal Instability and Tumorigenesis

$293,037
Jan M. Van Deursen · Mayo Clinic Rochester · R01 · FY2012 · CA

Biomarkers of the Proinflammatory Response and Elements of Immune Suppression

$292,902
Ahmad A. Tarhini · University Of Pittsburgh At Pittsburgh · P50 · FY2017 · CA

Project 4: Immunovirotherapy

$292,832
Richard G Vile · Mayo Clinic Rochester · P50 · FY2019 · CA

Res Proj 2: Molecular Imaging Strategies to Study Cdc25A Regulation in vivo

$292,712
Helen M Piwnica-Worms · Washington University · P50 · FY2009 · CA

Project 2

$292,668
Felicity Harper · Wayne State University · P20 · FY2021 · CA

Targeting Cell Cycle Machinery For Cancer Therapy

$292,538
E Premkumar Reddy · Temple Univ Of The Commonwealth · R01 · FY2007 · CA